News
-
Guild, PSA slam Grattan Report
Monday | Mar 6 2017A new report from the Grattan Institute released yesterday claims Australians pay more than $500 million a year for prescription drugs, and urges changes to the way prices are set under the Pharmaceutical Benefits Scheme.
-
Review draft report delay
Monday | Mar 6 2017THE Health Department has confirmed that the promised Interim Report for the Review of Pharmacy Remuneration and Regulation would not be delivered as originally scheduled.
-
Samples, training and deals
Monday | Mar 6 2017TODAY sees the launch of a comprehensive new service for pharmacy and other healthcare professionals providing offers of free product samples, representative visits and training for staff as well as deals for pharmacy.
-
Canadian cannabis import
Monday | Mar 6 2017NORTH American pharmaceutical-grade medicinal cannabis producer Tilray, the first to be certified in accordance with the European Medicines Agency's (EMA) Good Manufacturing Practice (GMP), announced that it had successfully exported medical cannabis products to Victoria, Australia.
-
Events Calendar 03 Mar 17
Friday | Mar 3 2017WELCOME to Pharmacy Daily’s events calendar, opportunities to earn CPE and CPD points.
-
Dust mite approval
Friday | Mar 3 2017THE US Food and Drug Administration has approved Odactra, a new "allergen extract" to treat house dust mite-induced nasal and eye inflammation.
-
New Allergan leads
Friday | Mar 3 2017ALLERGAN plc has announced that its current managing director for Australia, Glen Curren, has been appointed to a new leadership role in the company's European Region and will be relocating to the United Kingdom.
-
Early bird closing
Friday | Mar 3 2017THE early bird registration discount for registration to attend the 5th BioCeuticals Research Symposium, "the event calendar highlight of the integrative medicine industry" expires next Fri.
-
US, EU sign GMP pact
Friday | Mar 3 2017THE United States and the European Union have agreed to extend their existing cooperation so they will be able to utilise each other's good manufacturing practice (GMP) inspections of pharmaceuticals facilities.